U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209296

CINVANTI (APREPITANT)
130MG/18ML (7.2MG/ML)
Marketing Status: Prescription
Active Ingredient: APREPITANT
Proprietary Name: CINVANTI
Dosage Form; Route of Administration: EMULSION; INTRAVENOUS
Strength: 130MG/18ML (7.2MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209296
Product Number: 001
Approval Date: Nov 9, 2017
Applicant Holder Full Name: HERON THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top